178 related articles for article (PubMed ID: 14991239)
1. alpha-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells.
Ramanathapuram LV; Kobie JJ; Bearss D; Payne CM; Trevor KT; Akporiaye ET
Cancer Immunol Immunother; 2004 Jul; 53(7):580-8. PubMed ID: 14991239
[TBL] [Abstract][Full Text] [Related]
2. Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines.
Ramanathapuram LV; Hahn T; Graner MW; Katsanis E; Akporiaye ET
Cancer Immunol Immunother; 2006 Feb; 55(2):166-77. PubMed ID: 16041582
[TBL] [Abstract][Full Text] [Related]
3. Chemo-immunotherapy of breast cancer using vesiculated alpha-tocopheryl succinate in combination with dendritic cell vaccination.
Ramanathapuram LV; Hahn T; Dial SM; Akporiaye ET
Nutr Cancer; 2005; 53(2):177-93. PubMed ID: 16573379
[TBL] [Abstract][Full Text] [Related]
4. Tocotrienols are good adjuvants for developing cancer vaccines.
Hafid SR; Radhakrishnan AK; Nesaretnam K
BMC Cancer; 2010 Jan; 10():5. PubMed ID: 20051142
[TBL] [Abstract][Full Text] [Related]
5. Superior anti-tumor protection and therapeutic efficacy of vaccination with dendritic cell/tumor cell fusion hybrids for murine Lewis lung carcinoma.
Chen X; Liu Z; Huang Y; Li R; Zhang H; Dong S; Ge C; Zhang Z; Wang Y; Wang Y; Xue Y; Li Z; Song X
Autoimmunity; 2014 Feb; 47(1):46-56. PubMed ID: 24191684
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic immune response induced by electrofusion of dendritic and tumor cells.
Tanaka H; Shimizu K; Hayashi T; Shu S
Cell Immunol; 2002 Nov; 220(1):1-12. PubMed ID: 12718934
[TBL] [Abstract][Full Text] [Related]
7. Fusion of CpG-ODN-stimulating dendritic cells with Lewis lung cancer cells can enhance anti-tumor immune responses.
Du YC; Lin P; Zhang J; Lu YR; Ning QZ; Wang Q
Tissue Antigens; 2006 May; 67(5):368-76. PubMed ID: 16671943
[TBL] [Abstract][Full Text] [Related]
8. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
Pan JP; Weng YS; Wu QQ
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
[TBL] [Abstract][Full Text] [Related]
9. The Application of Cytidyl Guanosyl Oligodeoxynucleotide Can Affect the Antitumor Immune Response Induced by a Combined Protocol of Cryoablation and Dendritic Cells in Lewis Lung Cancer Model.
Zhang M; Yin T; Lu Y; Feng H
Med Sci Monit; 2016 Apr; 22():1309-17. PubMed ID: 27092689
[TBL] [Abstract][Full Text] [Related]
10. Short-term dietary administration of celecoxib enhances the efficacy of tumor lysate-pulsed dendritic cell vaccines in treating murine breast cancer.
Hahn T; Alvarez I; Kobie JJ; Ramanathapuram L; Dial S; Fulton A; Besselsen D; Walker E; Akporiaye ET
Int J Cancer; 2006 May; 118(9):2220-31. PubMed ID: 16331615
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy for Lewis lung carcinoma utilizing dendritic cells infected with CK19 gene recombinant adenoviral vectors.
Sun QF; Zhao XN; Peng CL; Hao YT; Zhao YP; Jiang N; Xue H; Guo JZ; Yun CH; Cong B; Zhao XG
Oncol Rep; 2015 Nov; 34(5):2289-95. PubMed ID: 26323510
[TBL] [Abstract][Full Text] [Related]
12. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294
[TBL] [Abstract][Full Text] [Related]
13. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
Zhang W; He L; Cao X
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032
[TBL] [Abstract][Full Text] [Related]
14. [Dendritic cell-tumor cell fusion vaccine prevents growth of subcutaneous transplanted esophageal carcinomas].
Deng YJ; Zhang LJ; Su XD; Zhang DK; Rong TH; Wang QJ; Xia JC
Ai Zheng; 2009 Oct; 28(10):1067-71. PubMed ID: 19799815
[TBL] [Abstract][Full Text] [Related]
15. Local secretion of IL-12 augments the therapeutic impact of dendritic cell-tumor cell fusion vaccination.
Tan C; Dannull J; Nair SK; Ding E; Tyler DS; Pruitt SK; Lee WT
J Surg Res; 2013 Dec; 185(2):904-11. PubMed ID: 23891424
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma.
Xie J; Xiong L; Tao X; Li X; Su Y; Hou X; Shi H
Lung Cancer; 2010 Jun; 68(3):338-45. PubMed ID: 19671483
[TBL] [Abstract][Full Text] [Related]
17. Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant, elicits a specific antitumor immunity.
Alteber Z; Azulay M; Cafri G; Vadai E; Tzehoval E; Eisenbach L
Cancer Immunol Immunother; 2014 Apr; 63(4):369-80. PubMed ID: 24452202
[TBL] [Abstract][Full Text] [Related]
18. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of dendritic cell-tumor fusion vaccine potency by indoleamine-pyrrole 2,3-dioxygenase inhibitor, 1-MT.
Ou X; Cai S; Liu P; Zeng J; He Y; Wu X; Du J
J Cancer Res Clin Oncol; 2008 May; 134(5):525-33. PubMed ID: 17909857
[TBL] [Abstract][Full Text] [Related]
20. Enhanced therapeutic efficacy of tumor RNA-pulsed dendritic cells after genetic modification with lymphotactin.
Zhang W; He L; Yuan Z; Xie Z; Wang J; Hamada H; Cao X
Hum Gene Ther; 1999 May; 10(7):1151-61. PubMed ID: 10340547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
